ClinicalTrials.Veeva

Menu

Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock.

A

Assiut University

Status

Not yet enrolling

Conditions

Doppler Echocardiography
Postpartum Septic Shock

Treatments

Procedure: a transthoracic bedside focused echocardiographic assessment
Procedure: a clinically guided resuscitation protocol,

Study type

Interventional

Funder types

Other

Identifiers

NCT06757985
Doppler echocardiography

Details and patient eligibility

About

Postpartum sepsis is widely known as a preventable main cause of maternal morbidity and mortality. According to the World Health Organization, approximately 11% of the estimated maternal deaths worldwide were attributed to sepsis. Recent global assessments indicate that obstetric infections rank as the third most prevalent cause of maternal death, with a prevalence mainly observed in low- and middle-income nations.

Full description

The management of septic shock is a major medical concern. Early goal-directed therapy emerged as a novel approach for reducing sepsis mortality and was incorporated into Surviving Sepsis Campaign guidelines in 2012. Early detection of sepsis, rapid initiation of antibiotics and effective resuscitation with fluids, vasopressors, and inotropes were important concerns. However, many randomized trials were done to examine the effect of EGDT on morbidity and mortality and showed that EGDT was not associated with a significant reduction in mortality in patients with septic shock compared to usual care. That it wasn't addressed in recent guidelines in 2016 and 2021.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • postpartum women, within 6 weeks following delivery
  • meeting the third international consensus definitions for septic Shock (2016) (Sepsis-3): acute persisting hypotension requiring vasopressors to maintain mean arterial pressure (MAP) ≥ 65 mm Hg and having a serum lactate > 2 mmol/L (18 mg/dL) despite adequate volume resuscitation

Exclusion criteria

  • Patient refusal
  • History of any chronic cardiac disease
  • Requirement for immediate surgery
  • Hypotension attributable to another cause
  • Do-not-resuscitate status
  • Contraindication to central venous catheter placement
  • Difficult transthoracic echocardiographic evaluation
  • Primary cardiogenic cause of shock, instead of sepsis.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

CTGT group
Experimental group
Description:
a clinically guided resuscitation protocol, derived from EGDT
Treatment:
Procedure: a clinically guided resuscitation protocol,
ECHO group
Experimental group
Description:
a transthoracic bedside focused echocardiographic assessment of the patient
Treatment:
Procedure: a transthoracic bedside focused echocardiographic assessment

Trial contacts and locations

1

Loading...

Central trial contact

Ghada Abo Elfadl, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems